TELA - TELA Bio, Inc.
0.78
-0.020 -2.526%
Share volume: 90,870
Last Updated: 04-28-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$0.80
-0.02
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-10-2024 | 08-13-2024 | 11-08-2024 | 03-21-2025 | 05-08-2025 | 11-14-2025 | 03-25-2026 | |
| Total revenue | 16.603 M | 16.091 M | 18.957 M | 17.649 M | 18.520 M | 20.689 M | 20.869 M | |
| Cost of revenue | 5.267 M | 5.018 M | 6.099 M | 6.428 M | 6.008 M | 6.720 M | 6.734 M | |
| Gross profit | 11.336 M | 11.073 M | 12.858 M | 11.221 M | 12.512 M | 13.969 M | 13.755 M | |
| -2.32% | 16.12% | -12.73% | 11.51% | 11.64% | -1.53% | |||
| Operating expenses | 6.222 M | 5.944 M | 5.751 M | 5.618 M | 6.376 M | 6.296 M | 5.913 M | |
| Selling general and admin | 3.829 M | 3.621 M | 3.683 M | 3.589 M | 3.836 M | 3.948 M | 3.784 M | |
| Research and development | 2.393 M | 2.323 M | 2.068 M | 2.029 M | 2.540 M | 2.348 M | 2.129 M | |
| Total expenses | 16.162 M | 22.643 M | 22.223 M | 19.575 M | 22.984 M | 21.523 M | 20.403 M | |
| 40.10% | -1.85% | -11.92% | 17.42% | -6.36% | -5.20% | |||
| Operating income | -4.826 M | -11.570 M | -9.365 M | -8.354 M | -10.472 M | -7.554 M | -6.648 M | |
| Ebit | -4.329 M | -11.269 M | -9.028 M | -8.069 M | -9.993 M | -7.402 M | -6.371 M | |
| Pretax income | -5.661 M | -12.600 M | -10.372 M | -9.352 M | -11.212 M | -8.603 M | -8.896 M | |
| 122.58% | -17.68% | -9.83% | 19.89% | -23.27% | 3.41% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 52.000 K | 0.000 | 145.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -5.661 M | -12.600 M | -10.372 M | -9.208 M | -11.264 M | -8.603 M | -9.041 M | |
| -122.58% | 17.68% | 11.22% | -22.33% | 23.62% | -5.09% |